If you have trouble reading this, please click http://www.freedomofresearch.org/sites/default/files/freedom23.html World Congress for Freedom of Scientific Research the bulletin Number 23, April 2011 Embryo’s patentability, your comments. In response to newsletter no. 22, Bernard Siegel, Executive Director and founder of Genetics Policy Institute (GPI), sent his opinion on patentability of biotechnology inventions: “In a sense,